USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medos International Sarl

USPTO PatentsView assignee record - 535 granted patents across 40 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

535
Total patents granted
40
CPC technology areas
17.9
Avg claims per patent
+134%
5-year filing velocity

The verdict

Medos holds 535 US patents across 40 technology areas, rank #852 of 50,000 tracked assignees.

#852
of 50,000 US assignees by volume
Top 3%
by Innovation Score (62.0/100)
17.9
avg claims per patent
+134%
filing velocity, last 5 yrs

Portfolio overview

Medos International Sarl has been granted 535 US utility patents between 2015 and 2025, placing Medos International Sarl at rank #852 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medos International Sarl is one of the more focused assignees in the PatentsView dataset. By volume, Medos sits between Paccar Inc (538 patents, rank #848) and Nuflare Technology, Inc. (533 patents, rank #856) - the closest US assignees by grant volume. The composite Innovation Score of 62.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 375 grants, compared with 160 in the 2015–2019 window, a +134% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medos International Sarl's 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 40 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medos International Sarl against peers pursuing similar technology classes.

Who files at Medos's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medos holds 535 patents at rank #852, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medos

By rank, the assignees closest to #852 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medos's primary technology class.

Medos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

020406080 20152016201720182019202020212022202320242025 54
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medos International Sarl patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 20 3.7%
2016 22 4.1%
2017 22 4.1%
2018 33 6.2%
2019 63 11.8%
2020 61 11.4%
2021 61 11.4%
2022 68 12.7%
2023 66 12.3%
2024 65 12.1%
2025 54 10.1%

Which technologies does Medos International Sarl patent most?

Top 15 of 40 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#852

Across all tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medos International Sarl hold?
Medos International Sarl holds 535 US granted patents filed between 2015 and 2025, spanning 40 technology areas.
What is Medos International Sarl's Innovation Score?
Medos International Sarl has an Innovation Score of 62.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medos International Sarl focus on?
Medos International Sarl's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 492 patents. The company has filed patents in 40 CPC subclasses total.
Is Medos International Sarl's patent filing rate increasing or decreasing?
Medos International Sarl's recent filing velocity is +134% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Medos International Sarl's patents?
Medos International Sarl's patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Medos International Sarl patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medos's 535 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Medos ranks #852 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.